Cargando…
Beta-Blocker Therapy Early After Myocardial Infarction: A Comparison Between Medication at Hospital Discharge and Subsequent Pharmacy-Dispensed Medication
BACKGROUND: Beta-blocker (BB) therapy after myocardial infarction (MI) reduces all-cause mortality. OBJECTIVE: The aim of this study was to investigate BB dosing patterns and compliance following MI. METHODS: Using medical patient files and nationwide databases, we identified 100 patients who were d...
Autores principales: | Pedersen, Susanne Bendesgaard, Nielsen, Jens Cosedis, Bøtker, Hans Erik, Goldberger, Jeffrey J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042935/ https://www.ncbi.nlm.nih.gov/pubmed/27747827 http://dx.doi.org/10.1007/s40801-016-0079-0 |
Ejemplares similares
-
Beta-Blocker Use after Discharge in Patients with Acute Myocardial Infarction in the Contemporary Reperfusion Era
por: Hu, Mengjin, et al.
Publicado: (2022) -
One‐Year Landmark Analysis of the Effect of Beta‐Blocker Dose on Survival After Acute Myocardial Infarction
por: Goldberger, Jeffrey J., et al.
Publicado: (2021) -
Assessment of Medication Dispensing and Extended Community Pharmacy Services
por: Ibrahim, Mohamed Izham Mohamed
Publicado: (2018) -
Medication Risk Management in Routine Dispensing in Community Pharmacies
por: Kallio, Sonja, et al.
Publicado: (2020) -
Impact of preadmission treatment with calcium channel blockers or beta blockers on short-term mortality after stroke: a nationwide cohort study
por: Sundbøll, Jens, et al.
Publicado: (2015)